Home / Community / News

News

06/02/2017 - 4:17pm

MDF strives to help National Institutes of Health (NIH) grant applicants compete for research funding.

06/02/2017 - 4:00pm

Taking as many shots on goal as possible is the only path to approval and reimbursement of safe and effective drugs for DM.

06/02/2017 - 3:53pm

MDF staff recently attended the 2017 annual meeting of the American Academy of Neurology, in Boston, MA. Here are highlights from that meeting.

05/25/2017 - 11:19am

MDF held the first myotonic dystrophy (DM) Patient-Focused Drug Development (PFDD) meeting with key senior leaders from the Food and Drug Administration (FDA) as part of the 2016 MDF Annual Conference in September 2016.

05/15/2017 - 3:12pm

There have been new discoveries in the way that congenital myotonic dystrophy (CDM) is inherited.

Partners

© Myotonic Dystrophy Foundation. All rights reserved.